Development of New Coumarin-Based Profluorescent Substrates for Human Cytochrome P450 Enzymes
Juvonen, R. O., Ahinko, M., Huuskonen, J., Raunio, H., & Pentikäinen, O. (2019). Development of New Coumarin-Based Profluorescent Substrates for Human Cytochrome P450 Enzymes. Xenobiotica, 49(9), 1015-1024. https://doi.org/10.1080/00498254.2018.1530399
© Informa Healthcare, 2019.
1. Cytochrome P450 (CYP) enzymes constitute an essential xenobiotic metabolizing system that regulates the elimination of lipophilic compounds from the body. Convenient and affordable assays for CYP enzymes are important for assessing these metabolic pathways. 2. In this study, 10 novel profluorescent coumarin derivatives with various substitutions at carbons 3, 6 and 7 were developed. Molecular modeling indicated that 3- phenylcoumarin offers an excellent scaffold for the development of selective substrate compounds for various human CYP forms, as they could be metabolized to fluorescent 7-hydroxycoumarin derivatives. Oxidation of profluorescent coumarin derivatives to fluorescent metabolites by 13 important human liver xenobiotic-metabolizing CYP forms was determined by enzyme kinetic assays. 3. Four of the coumarin derivatives were converted to fluorescent metabolites by CYP1 family enzymes, with 6-methoxy-3-(4-trifluoromethylphenyl)coumarin being oxidized selectively by CYP1A2 in human liver microsomes. Another set of four compounds were metabolized by CYP2A6 and CYP1 enzymes. 7-Methoxy-3-(3- methoxyphenyl)coumarin was oxidized efficiently by CYP2C19 and CYP2D6 in a nonselective fashion. 4. The advantages of the novel substrates were 1) an excellent signal-to-background ratio, 2) selectivity for CYP1 forms, and 3) convenient multiwell plate measurement, allowing for precise determination of potential inhibitors of important human hepatic forms CYP1A2, CYP2C19 and CYP2D6. ...
Publication in research information system
MetadataShow full item record
Showing items with similar title or keywords.
Substrate Selectivity of Coumarin Derivatives by Human CYP1 Enzymes : In Vitro Enzyme Kinetics and In Silico Modeling Juvonen, Risto O.; Ahinko, Mira; Jokinen, Elmeri M.; Huuskonen, Juhani; Raunio, Hannu; Pentikäinen, Olli T. (American Chemical Society (ACS), 2021)Of the three enzymes in the human cytochrome P450 family 1, CYP1A2 is an important enzyme mediating metabolism of xenobiotics including drugs in the liver, while CYP1A1 and CYP1B1 are expressed in extrahepatic tissues. ...
Molecular docking-based design and development of a highly selective probe substrate for UDP-glucuronosyltransferase 1A10 Juvonen, Risto O.; Rauhamäki, Sanna; Kortet, Sami; Niinivehmas, Sanna; Troberg, Johanna; Petsalo, Aleksanteri; Huuskonen, Juhani; Raunio, Hannu; Finel, Moshe; Pentikäinen, Olli (American Chemical Society, 2018)Intestinal and hepatic glucuronidation by the UDP-glucuronosyltransferases (UGTs) greatly affect the bioavailability of phenolic compounds. UGT1A10 catalyzes glucuronidation reactions in the intestine, but not in the liver. ...
Juvonen, Risto O.; Jokinen, Elmeri M.; Huuskonen, Juhani; Kärkkäinen, Olli; Raunio, Hannu; Pentikäinen, Olli T. (Informa Healthcare, 2021)1.CYP2A13 enzyme is expressed in human extrahepatic tissues, while CYP2A6 is a hepatic enzyme. Reactions catalyzed by CYP2A13activate tobacco-specificnitrosamines and some other toxic xenobioticsin lungs. 2.To compare ...
Tossavainen, Helena; Raulinaitis, Vytas; Kauppinen, Linda; Pentikäinen, Ulla; Maaheimo, Hannu; Permi, Perttu (Frontiers Research Foundation, 2018)Lysostaphin from Staphylococcus simulans and its family enzymes rapidly acquire prominence as the next generation agents in treatment of S. aureus infections. The specificity of lysostaphin is promoted by its C-terminal ...
Determining the substrate specificity of two lysostaphin enzyme family members using NMR spectroscopy Jartti, Minne (2020)Yksi merkittävimmistä ihmisen patogeeneista on Staphylococcus aureus-bakteeri. Se aiheuttaa erityyppisiä vakavia infektioita kuten verenmyrkytystä ja sydämen sisäkalvon tulehdusta, sekä lievempiä ihotulehduksia ja ...